Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA
While it may not seem controversial to promote honesty before the USPTO, a recent Federal Register Notice goes far beyond requiring candor.
Intellectual Property
-
Read more: Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA -
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
-
Read more: COVID-19, Patents, and Trade Secrets COVID-19, Patents, and Trade Secrets
Has the global distribution of COVID-19 vaccines been impacted by patent rights? David Gindler and Jasper L. Tran argue that the story is complicated.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from April 2022.
-
Read more: The Proposed TRIPS Compromise Risks Setting Several Bad Precedents The Proposed TRIPS Compromise Risks Setting Several Bad Precedents
The proposal introduces precedents that will be used to justify further narrowing of TRIPS flexibilities.
-
Read more: Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation
We are excited to welcome our inaugural group of affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR).
-
Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach COVID ‘Compromise’ on International IP Underscores Need for New Approach
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
-
Read more: Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics
Research funding contracts can help to safeguard against inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines.
-
Read more: Graduate Students’ Curricula Should Include Intellectual Property Graduate Students’ Curricula Should Include Intellectual Property
Science and engineering graduate students’ curricula should include cross-disciplinary studies in intellectual property (IP).
